Stockreport

Aligos Therapeutics up on FDA clearance of IND application for its Hepatitis B treatment [Seeking Alpha]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF FDA has cleared the company's Investigational New Drug for a Phase 1 Drug-Drug Interaction study of ALG-000184, a capsid assembly modulator for the treatment of Chronic [Read more]